1-3 of 3
Christopher M Borges, PhD BS
Close
Sort by
Journal Articles

Preclinical Development of Edit-201, a Multigene Edited Healthy Donor NK Cell with Enhanced Anti-Tumor Function and Superior Serial Killing Activity in an Immunosuppressive Environment

Christopher M Borges, PhD BS, Kevin Wasko, Jared M Nasser, Kelly Donahue, Amanda Pfautz, Lincy P Antony, Glenn Leary, Steven Sexton, Richard A. Morgan, PhD, Karrie K Wong, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-139988
Published: 2020
Journal Articles

Generation of Natural Killer Cells with Enhanced Function from a CRISPR/Cas12a-Edited Induced Pluripotent Stem Cell Line

Jung-Il Moon, PhD, Melissa S Chin, BS, Andrew T Burden, BS, Steven Sexton, Kevin Wasko, Jared M Nasser, Lincy P Antony, Karrie K Wong, PhD, Christopher M Borges, PhD BS, Richard A. Morgan, PhD, G. Grant Welstead, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-139471
Published: 2020
Journal Articles

Inhibiting TGFβ Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor Immunotherapy

Queenie Vong, PhD, Chris Nye, MBT, Ron Hause, PhD, Chris Clouser, PhD, Jon Jones, BS, Stephen Burleigh, Christopher M Borges, PhD BS, Melissa Si Ying Chin, BS, Eugenio Marco, Luis Barrera, Jen Da Silva, Fred Harbinski, Georgia Giannoukos, Vidya Dhanapal, Yue Jiang, PhD, Ruth Salmon, PhD, Christopher J Wilson, PhD, Vic E Myer, PhD, Grant G Welstead, PhD, Christopher J Bond, PhD, Blythe Duke Sather, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1791.
https://doi.org/10.1182/blood.V130.Suppl_1.1791.1791
Published: 2017